Ms. Shivangi Sharma | Chemistry | Best Researcher Award

Ms. Shivangi Sharma , Chemistry , Amity University Gwalior, India

Shivangi Sharma is a Ph.D. Research Scholar at Amity University Gwalior, specializing in Molecular Design, Synthesis, and Biological Evaluation of Quinoline and Indole-based Derivatives. With a strong foundation in Synthetic Organic Chemistry and Heterocyclic Chemistry, she is focused on developing novel compounds with antibacterial and antifungal properties. Her research is driven by the design of heterocyclic organic molecules for potential biological activity, alongside applications in drug synthesis and molecular docking. Shivangi has authored 16 research papers published in SCI & Scopus indexed journals, conferences, and book chapters. Additionally, she has contributed to a book published by Notion Press. Her dedication to advancing pharmaceutical sciences and organic chemistry has earned her recognition, and she is also well-versed in techniques like in silico molecular docking, protein-ligand interaction, and organic synthesis.

Publication Profile

Google Scholar

Orcid

Scopus

Academic Background🎓

Shivangi Sharma pursued her Master of Science in Chemistry from the School of Studies, Jiwaji University, Gwalior, where she secured third position. Currently, she is completing her Ph.D. in Applied Science at Amity University Gwalior under the mentorship of Prof. (Dr.) Mohana Lakshmi Sabapathi, Director, and Principal of the Amity Institute of Pharmacy. Her academic background has equipped her with a robust understanding of various aspects of chemistry, particularly in synthetic organic chemistry, heterocyclic chemistry, and drug design. Shivangi has developed a strong interest in molecular docking, protein-ligand interactions, and drug delivery systems, applying these skills to her ongoing research. Her training also includes exposure to modern synthetic techniques, such as multi-component reactions and organocatalysis. Through her rigorous education and research endeavors, she has honed her skills in scientific research, contributing significantly to her field of study.

Professional Background🏅

Shivangi Sharma’s research experience spans various domains of synthetic organic chemistry and drug design. She is currently pursuing her Ph.D. at Amity University Gwalior, where she focuses on the molecular design and synthesis of quinoline and indole-based derivatives with potential antibacterial and antifungal properties. Her expertise includes organic synthesis, purification, and characterization of chemical compounds on both small and medium scales. She has honed her skills in handling sensitive reactions and reagents in inert conditions. Additionally, Shivangi has gained experience in modern drug delivery systems, including preparation and characterization techniques. Through her involvement in the CSIR Summer Research Training Program (2020), she gained expertise in carbon nanotubes and further enhanced her skills in molecular docking and structure determination using UV, FTIR, NMR, and Mass Spectroscopy. Shivangi’s work integrates multi-disciplinary approaches, showcasing her ability to conduct independent research and contribute to the scientific community.

Awards and Honors🏆

Shivangi Sharma’s academic excellence is reflected in her awards and honors. She secured the third position in her Master of Science in Chemistry from Jiwaji University, Gwalior, highlighting her dedication and hard work in the field of chemistry. Shivangi’s pursuit of research excellence is further exemplified by her ongoing Ph.D. work at Amity University Gwalior, where she is under the mentorship of Prof. (Dr.) Mohana Lakshmi Sabapathi. Additionally, she was selected for the prestigious CSIR Summer Research Training Program (2020), where she gained valuable experience in carbon nanotubes and molecular docking. Her contributions to scientific research have resulted in the publication of 16 papers in renowned SCI & Scopus indexed journals, conference proceedings, and book chapters. Shivangi has also authored a book published by Notion Press, marking her academic and scholarly accomplishments. Her dedication to research and the sciences has earned her recognition and respect within the academic community.

Research Focus🔬

Shivangi Sharma’s research focus lies at the intersection of Synthetic Organic Chemistry, Heterocyclic Chemistry, and Drug Design. Specifically, she is dedicated to the molecular design, synthesis, and biological evaluation of quinoline and indole-based derivatives for their potential antibacterial and antifungal properties. Her research aims to explore novel drug molecules and their effectiveness in combating microbial infections. She is also deeply interested in the fields of molecular docking, protein-ligand interactions, and in silico drug design, utilizing computational tools to predict and optimize the biological activity of synthesized compounds. Shivangi’s work is grounded in organic synthesis techniques, including one-pot strategies, multi-component reactions, and organocatalysis. She applies modern synthetic chemistry to design compounds with high therapeutic potential and bioactivity. Additionally, her research aims to explore novel drug delivery systems and their applications in pharmaceutical development, ensuring her work has both academic and practical relevance in the field of medicinal chemistry.

Publication Top Notes

2-Oxindole and related heterocycles: synthetic methodologies for their natural products and related derivatives

Citations: 37

Synthetic strategies for Quinoline based derivatives as potential bioactive heterocycles

Citations: 16

Synthetic routes to quinoline-based derivatives having potential anti-bacterial and anti-fungal properties

Citations: 16

Molecular Docking Study for Binding Affinity of 2H-thiopyrano [2, 3-b] quinoline Derivatives against CB1a

Citations: 15

In silico screening and molecular docking study of quinoline based compounds with Human kallikrein 7 in complex with 1, 4-diazepane-7-one 1-acetamide derivative receptor target

Citations: 14

The Biological and Pharmacological Potentials of Indole-based Heterocycles

Citations: 14

Quinoline-Based Anti-Oncogenic Molecules: Synthesis and Biological Evaluation

Citations: 11

Simplified procedure for application of DBE, the rule of 13 & Nitrogen rule in structure elucidation of organic compounds

Citations: 7

Molecular docking study for binding affinity of Indole derivatives against solution structure of the antimicrobial peptide Btd-2

Citations: 5

Bioactive indole heterocycles and their synthetic routes: a comprehensive review

Citations: 5

Biochar, clay, zeolites, and microorganism-based methods for remediation of heavy metals

Citations: 4

Molecular Docking Study of 2, 3, 4-trisubstituted-2, 3, 4, 9-Tetrahydrothiopyrano [2, 3-b] indole Derivatives with TRPV channels: Possible New Analgesics

Citations: 3

Conclusion

Based on her research contributions, publications, awards, and ongoing work, Shivangi Sharma is a strong contender for the “Best Researcher Awards.” Her passion for the synthesis of biologically active compounds, her expertise in drug design and molecular docking, and her proven ability to publish quality research make her an exemplary candidate for such recognition. Furthermore, her ability to independently carry out experiments, interpret data, and innovate in her field positions her as a future leader in the area of synthetic organic chemistry and medicinal chemistry. Therefore, Shivangi Sharma’s research trajectory and impact on her field make her highly suitable for the “Best Researcher Awards.”

Assoc Prof Dr. Irem kulu | Organic Chemistry | Best Researcher Award

Assoc Prof Dr. Irem kulu, Gebze Technical University, Turkey

Assoc. Prof. Dr. İrem Kulu is an accomplished organic chemist with a PhD from Yıldız Technical University, Turkey. Her expertise lies in C-C and C-N bond formation reactions of cyclic systems. With a diverse background including roles at Novartis and UMASS Amherst, she’s currently an Associate Professor at Gebze Technical University. Her research spans various projects, notably focusing on drug synthesis and bioorthogonal nanozymes. As a project coordinator and researcher, she contributes significantly to TÜBİTAK-funded initiatives. 🧪🔬 Passionate about synthesizing novel compounds, her work holds promise for advancing medicinal chemistry.

Publication Profile:

Scopus

Google Scholar

Education:

Dr. İrem Kulu is a dedicated scholar in organic chemistry, graduating from Yıldız Technical University in Turkey. She completed her Bachelor of Science, Master of Science, and PhD degrees from the Department of Organic Chemistry at the same institution. Her research journey began with her Bachelor’s thesis focusing on the synthesis of organic compounds. In her Master’s thesis, she explored Domino Heck type Hydroarylation reactions and new isoindolines. For her doctoral work, she delved into C-C and C-N bond formation reactions of cyclic systems. Under the guidance of Prof. Dr. Zehra Nüket Öcal Sunguroğlu, she demonstrated a keen interest in advancing organic synthesis. 🎓🔬

Experience :

Dr. İrem Kulu’s career spans diverse roles in academia and industry, showcasing her expertise in organic chemistry. She began as a post-doctoral researcher at Gebze Technical University, contributing to TÜBİTAK projects focused on hybrid materials synthesis. Transitioning to industry, she served as a Synthesis Chemist at Novartis, specializing in API synthesis. Her academic journey continued as an Assistant Professor at Gebze Technical University, where she eventually ascended to Associate Professor. Notably, she pursued post-doctoral research at UMASS Amherst, delving into bioorthogonal nanozymes. Her multifaceted experience reflects a commitment to advancing chemical science across academia and industry. 🔬👩‍🔬

Research Focus:

Dr. İrem Kulu’s research primarily focuses on organic synthesis and medicinal chemistry, as evidenced by her extensive publication record. She has contributed significantly to the development of novel compounds with potential pharmacological applications, including antidepressants, antimicrobials, and anticancer agents. Her work spans various synthetic methodologies, such as Domino-Heck reactions, reductive Heck reactions, and [3+2] cycloadditions, aiming to create diverse molecular architectures. Additionally, she explores the physicochemical properties and biological activities of synthesized compounds, particularly their interactions with metal ions and their potential as photosensitizers. Dr. Kulu’s research embodies a quest for innovative solutions in drug discovery and development. 💊🔬

Shivangi Sharma | Chemistry | Best Researcher Award